Dataset from The Efficacy And Safety Of Flexible Dose Ranges Of Risperidone Versus Placebo Or Haloperidol In The Treatment Of Manic Episodes Associated With Bipolar I Disorder.

The purpose of the study is to assess the effectiveness and safety of risperidone (an antipsychotic medication) compared with placebo after 3 weeks of treatment in patients with bipolar disorder who are experiencing manic episodes. A secondary purpose of the study is to assess the maintenance of risperidone effectiveness versus haloperidol (an antipsychotic medication) after 12 weeks of treatment.

本研究旨在评估双相情感障碍躁狂发作患者接受3周治疗后，利培酮（risperidone，一种抗精神病药物）与安慰剂相比的有效性与安全性。本研究的次要目的为评估12周治疗后，利培酮相较于氟哌啶醇（haloperidol，一种抗精神病药物）的疗效维持效果。